IHS Chemical Week

World News and Views :: Projects

Novozymes Opens Hyaluronic Acid Plant in China

6:19 AM MDT | May 9, 2012 | Deepti Ramesh

Novozymes says its Novozymes Biopharma business has begun commercial supply of hyaluronic acid from a previously announced new plant at Tianjin, China. The newly opened plant involved an investment of over DKK350 million ($61.4 million), and it supplies Novozymes Hyasis, a pharmaceutical-grade hyaluronic acid. The product targets medical device and pharmaceutical markets. “The market for pharmaceutical use of hyaluronic acid is estimated to be DKK1 billion,” says Thomas Videbæk, executive v.p. at Novozymes. “With regulations in the medical...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa